[go: up one dir, main page]

DE60229624D1 - Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion - Google Patents

Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion

Info

Publication number
DE60229624D1
DE60229624D1 DE60229624T DE60229624T DE60229624D1 DE 60229624 D1 DE60229624 D1 DE 60229624D1 DE 60229624 T DE60229624 T DE 60229624T DE 60229624 T DE60229624 T DE 60229624T DE 60229624 D1 DE60229624 D1 DE 60229624D1
Authority
DE
Germany
Prior art keywords
hiv
infection
treatment
peroxidedine
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60229624T
Other languages
English (en)
Inventor
Ralf Geiben Lynn
Bruce D Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE60229624D1 publication Critical patent/DE60229624D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01015—Peroxiredoxin (1.11.1.15)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60229624T 2001-03-23 2002-03-18 Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion Expired - Fee Related DE60229624D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27823401P 2001-03-23 2001-03-23
US10/057,593 US20020168353A1 (en) 2001-03-23 2002-01-25 Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof
PCT/US2002/008077 WO2002077294A1 (en) 2001-03-23 2002-03-18 Peroxiredoxin drugs for treatment of hiv-1 infection and methods of use thereof

Publications (1)

Publication Number Publication Date
DE60229624D1 true DE60229624D1 (de) 2008-12-11

Family

ID=26736676

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60229624T Expired - Fee Related DE60229624D1 (de) 2001-03-23 2002-03-18 Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion

Country Status (5)

Country Link
US (3) US20020168353A1 (de)
EP (1) EP1370697B1 (de)
AT (1) ATE412423T1 (de)
DE (1) DE60229624D1 (de)
WO (1) WO2002077294A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004043485A1 (en) * 2002-11-10 2004-05-27 Institute Of Cell Biophysics Russian Academy Of Sciences Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure
KR100610774B1 (ko) * 2005-02-03 2006-08-28 이화여자대학교 산학협력단 퍼록시레독신 2 단백질을 유효성분으로 함유하는 혈관재협착 예방 및 치료용 약학조성물, 퍼록시레독신 2유전자 또는 그로부터 발현되는 단백질을 포함하는 혈관재협착 치료제 스크리닝용 조성물 및 이를 이용하는 혈관재협착 치료제 스크리닝 방법
CA2782132A1 (en) * 2009-12-08 2011-06-16 Sandra O. Gollnick Methods and compositions using peroxiredoxin 1 (prx1) as an adjuvant
US20110177091A1 (en) * 2009-12-08 2011-07-21 Gollnick Sandra O Inhibition of Tumor Angiogenesis by Inhibition of Peroxiredoxin 1 (PRX1)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250295A (en) * 1991-11-04 1993-10-05 The Regents Of The Univ. Of California Natural killer cell enhancing factor
US5610286A (en) * 1991-11-04 1997-03-11 The Regents Of The University Of California DNA's encoding natural killer cell enhancing factor
AU2818695A (en) * 1995-06-06 1996-12-24 Human Genome Sciences, Inc. Natural killer cell enhancing factor c
US6150135A (en) * 1997-05-23 2000-11-21 Heska Corporation Dirofilaria and brugia thioredoxin peroxidase type-2 (TPX-2) nucleic acid molecules, and uses thereof

Also Published As

Publication number Publication date
EP1370697B1 (de) 2008-10-29
EP1370697A1 (de) 2003-12-17
US20020168353A1 (en) 2002-11-14
ATE412423T1 (de) 2008-11-15
US20060099199A1 (en) 2006-05-11
EP1370697A4 (de) 2004-04-14
US20090246821A1 (en) 2009-10-01
WO2002077294A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
NO20034056D0 (no) Proliferative sykdommer
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
ATE377657T1 (de) Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
ATE448775T1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
SE0302304D0 (sv) Novel compounds
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
WO2006034001A3 (en) Methods of treating hiv infection
YU68602A (sh) Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE60229624D1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
NO20005548L (no) Mykobakterieinhibitorer
ATE253936T1 (de) Glutathion-reduktase zur behandlung und prophylaxe von aids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee